Search

Your search keyword '"Kopylov, Uri"' showing total 1,115 results
Start Over Author "Kopylov, Uri" Search Limiters Academic (Peer-Reviewed) Journals
1,115 results on '"Kopylov, Uri"'

51. ECCO Guidelines on Inflammatory Bowel Disease and Malignancies

Author

Gordon, Hannah, Biancone, Livia, Fiorino, Gionata, Katsanos, Konstantinos H, Kopylov, Uri, Sulais, Eman Al, Axelrad, Jordan E, Balendran, Karthiha, Burisch, Johan, de Ridder, Lissy, Derikx, Lauranne, Ellul, Pierre, Greuter, Thomas, Iacucci, Marietta, Di Jiang, Caroline, Kapizioni, Christina, Karmiris, Konstantinos, Kirchgesner, Julien, Laharie, David, Lobatón Ortega, Triana, Molnár, Tamás, Noor, Nurulamin M, Rao, Rohit, Saibeni, Simone, Scharl, Michael, Vavricka, Stephan R, Raine, Tim, Gordon, Hannah, Biancone, Livia, Fiorino, Gionata, Katsanos, Konstantinos H, Kopylov, Uri, Sulais, Eman Al, Axelrad, Jordan E, Balendran, Karthiha, Burisch, Johan, de Ridder, Lissy, Derikx, Lauranne, Ellul, Pierre, Greuter, Thomas, Iacucci, Marietta, Di Jiang, Caroline, Kapizioni, Christina, Karmiris, Konstantinos, Kirchgesner, Julien, Laharie, David, Lobatón Ortega, Triana, Molnár, Tamás, Noor, Nurulamin M, Rao, Rohit, Saibeni, Simone, Scharl, Michael, Vavricka, Stephan R, and Raine, Tim

Published
2023

52. Idiopathic Thrombocytopenic Purpura associated with Inflammatory Bowel Disease : a multi-centre ECCO CONFER case series

Author

Mahajna, Hussein, Verstockt, Bram, Bergemalm, Daniel, Castiglione, Fabiana, Rodríguez-Moranta, Fransisco, Savarino, Edoardo Vincenzo, Hoentjen, Frank, Bessissow, Talat, Pokryszka, Jagoda, Cremer, Anneline, Eder, Piotr, Truyens, Marie, Yerushalmy-Feler, Anat, Garcia, Maria Jose, Kopylov, Uri, Mahajna, Hussein, Verstockt, Bram, Bergemalm, Daniel, Castiglione, Fabiana, Rodríguez-Moranta, Fransisco, Savarino, Edoardo Vincenzo, Hoentjen, Frank, Bessissow, Talat, Pokryszka, Jagoda, Cremer, Anneline, Eder, Piotr, Truyens, Marie, Yerushalmy-Feler, Anat, Garcia, Maria Jose, and Kopylov, Uri

Abstract

BACKGROUND: Idiopathic Thrombocytopenic Purpura (ITP) is an acquired haematological disorder with an incidence of 1 to 6 per 100,000/year. ITP and inflammatory bowel disease (IBD) comorbidity has been reported in the literature, but insights regarding the course, outcome and optimal management are limited by its rarity. The current study aimed to evaluate the clinical presentation and outcome of ITP in patients with IBD. METHODS: This multicentre retrospective case series was performed as part of the ECCO Collaborative Network of Exceptionally Rare case reports (CONFER) project. Cases of patients with ITP and IBD were collected by participating investigators. Clinical data were recorded in a standardised collection form. RESULTS: This report includes 32 patients with concurrent ITP and IBD:10 were females, median age was 32.0 [interquartile range (IQR) 20.5-39.5]. 14 patients had a diagnosis of Crohn's disease (CD) and the other 18 had of ulcerative colitis (UC). The diagnosis of IBD preceded the ITP in 26 patients (median time between diagnoses was 7.0 years [IQR, 1.5-9.5]). Among those patients, 17 patients were in clinical remission at ITP diagnosis. 13 patients were treated with mesalamine, 4 with oral corticosteroids, 1 with rectal corticosteroids, 2 with azathioprine, and 5 with anti-TNF agents. The median platelet count was 35,000/mmc (IQR, 10,000-70,000). 8 patients had rectal bleeding, 13 had skin purpura, 3 had epistaxis, 6 had mucosal petechiae, and 13 were asymptomatic. Regarding ITP treatment, 19 were treated with corticosteroids, 1 with Anti-RhD immunoglobulin, 12 with intravenous immunoglobulins (IVIG), 4 with thrombopoietin, 3 with rituximab and 6 patients eventually required splenectomy. 10 patients needed no treatment directed to the ITP.Three patients required colectomy during term long follow-up, due to IBD or cancer and not to massive bleeding as a complication of ITP. One patient of eight patients who presented with rectal bleeding required spl

Published
2023
Full Text
View/download PDF

53. Impact of Vedolizumab on Extraintestinal Manifestations in Inflammatory Bowel Disease: Results From a Descriptive, Retrospective, Real-world Study

Author

Kopylov, Uri; https://orcid.org/0000-0002-7156-0588, Burisch, Johan; https://orcid.org/0000-0002-3312-5139, Ben-Horin, Shomron, Braegger, Fiona, Fernández-Nistal, Alonso, Lara, Nuria, Heinrich, Henriette Sophie, Vavricka, Stephan R, Kopylov, Uri; https://orcid.org/0000-0002-7156-0588, Burisch, Johan; https://orcid.org/0000-0002-3312-5139, Ben-Horin, Shomron, Braegger, Fiona, Fernández-Nistal, Alonso, Lara, Nuria, Heinrich, Henriette Sophie, and Vavricka, Stephan R

Abstract

BACKGROUND Patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, may develop extraintestinal manifestations (EIMs). The EMOTIVE study aimed to analyze the effect of vedolizumab on EIMs in a real-world cohort of patients with IBD. METHODS This multicenter, descriptive, retrospective study was conducted in Belgium, Denmark, Israel, the Netherlands, and Switzerland in adults with moderately to severely active IBD and concurrent active EIMs at vedolizumab initiation (index date), with a ≥6-month follow-up after the index date. The primary endpoint was resolution of all EIMs within 6 months of vedolizumab initiation. RESULTS In 99 eligible patients, the most frequent EIMs were arthralgia (69.7%), peripheral spondyloarthritis (21.2%), and axial spondyloarthritis (10.1%). Within 6 and 12 months of vedolizumab initiation, 19.2% and 25.3% of patients reported resolution of all EIMs, while 36.5% and 49.5% of all EIMs were reported to be improved (combination of resolution and partial response), respectively. Vedolizumab treatment persistence at 12 months was 82.8%. Adverse events were reported in 18.2% of patients, with the most frequent being arthralgia (4.0%). CONCLUSIONS This real-world study showed resolution of all EIMs in up to one-fourth of patients with IBD and improvement in up to half of EIMs within 12 months of vedolizumab treatment. Overall, vedolizumab was effective on EIMs in patients with IBD and showed a good safety profile.

Published
2023

54. Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn's Disease: A Multi-Center Retrospective Cohort Study

Author

Albshesh, Ahmad; https://orcid.org/0000-0001-8962-4263, Bannon, Lian; https://orcid.org/0000-0002-5317-3613, Sharar Fischler, Tali, Truyens, Marie, Vavricka, Stephan R, Tepes, Katja; https://orcid.org/0000-0002-6131-0059, Pugliese, Daniela; https://orcid.org/0000-0001-7930-5402, Savarino, Edoardo V; https://orcid.org/0000-0002-3187-2894, Zittan, Eran, Drobne, David; https://orcid.org/0000-0003-2734-675X, Roblin, Xavier, Bar-Gil Shitrit, Ariella, Armuzzi, Alessandro; https://orcid.org/0000-0003-1572-0118, Lobaton, Triana; https://orcid.org/0000-0003-1817-7704, Maharshak, Nitsan, Yanai, Henit; https://orcid.org/0000-0001-5483-5271, Ben-Horin, Shomron, Kopylov, Uri, Albshesh, Ahmad; https://orcid.org/0000-0001-8962-4263, Bannon, Lian; https://orcid.org/0000-0002-5317-3613, Sharar Fischler, Tali, Truyens, Marie, Vavricka, Stephan R, Tepes, Katja; https://orcid.org/0000-0002-6131-0059, Pugliese, Daniela; https://orcid.org/0000-0001-7930-5402, Savarino, Edoardo V; https://orcid.org/0000-0002-3187-2894, Zittan, Eran, Drobne, David; https://orcid.org/0000-0003-2734-675X, Roblin, Xavier, Bar-Gil Shitrit, Ariella, Armuzzi, Alessandro; https://orcid.org/0000-0003-1572-0118, Lobaton, Triana; https://orcid.org/0000-0003-1817-7704, Maharshak, Nitsan, Yanai, Henit; https://orcid.org/0000-0001-5483-5271, Ben-Horin, Shomron, and Kopylov, Uri

Abstract

BACKGROUND The effectiveness of anti-TNF or ustekinumab (UST) as a second-line biologic after vedolizumab (VDZ) failure has not yet been described. AIMS AND METHODS In this retrospective multicenter cohort study, We aim to investigate the effectiveness of anti-TNF and UST as second-line therapy in patients with Crohn's disease (CD) who failed VDZ as a first-line treatment. The primary outcome was clinical response at week 16-22. Secondary outcomes included the rates of clinical remission, steroid-free clinical remission, CRP normalization, and adverse events. RESULTS Fifty-nine patients who failed on VDZ as a first-line treatment for CD were included; 52.8% patients received anti-TNF and 47.2% UST as a second-line therapy. In initial period (Week 16-22), the clinical response and remission rate was similar between both groups: 61.2% vs. 68%, p = 0.8 and 48.3% vs. 56%, p = 0.8 on anti-TNF and UST therapy, respectively. Furthermore, in the maintenance period the rate was similar: 75% vs. 82.3%, p = 0.8 and 62.5% vs. 70.5%, p = 0.8, respectively. Of the patients, 12 out of the 59 stopped the therapy, without a significant difference between the two groups (p = 0.6). CONCLUSION Second-line biological therapy after VDZ failure therapy was effective in >60% of the patients with CD. No differences in effectiveness were detected between the use of anti-TNF and UST as a second line.

Published
2023

62. Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study

Author

Fiorino, Gionata, Cortes, Pablo Navarro, Ellul, Pierre, Felice, Carla, Karatzas, Pantelis, Silva, Marco, Lakatos, Peter L., Bossa, Fabrizio, Ungar, Bella, Sebastian, Shaji, Furfaro, Federica, Karmiris, Konstantinos, Katsanos, Konstantinos H., Muscat, Martina, Christodoulou, Dimitrios K., Maconi, Giovanni, Kopylov, Uri, Magro, Fernando, Mantzaris, Gerassimos J., Armuzzi, Alessandro, Boscà-Watts, Marta Maia, Ben-Horin, Shomron, Bonovas, Stefanos, and Danese, Silvio

Published
2016
Full Text
View/download PDF

63. Prospective Observational Evaluation of Time-Dependency of Adalimumab Immunogenicity and Drug Concentrations: The POETIC Study

Author

Ungar, Bella, Engel, Tal, Yablecovitch, Doron, Lahat, Adi, Lang, Alon, Avidan, Benjamin, Har-Noy, Ofir, Carter, Dan, Levhar, Nina, Selinger, Limor, Neuman, Sandra, Natour, Ola Haj, Yavzori, Miri, Fudim, Ella, Picard, Orit, Kopylov, Uri, Chowers, Yehuda, Naftali, Timna, Broide, Efrat, Shachar, Eyal, Eliakim, Rami, and Ben-Horin, Shomron

Published
2018
Full Text
View/download PDF

65. Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn’s Disease: A Multi-Center Retrospective Cohort Study

Author

Albshesh, Ahmad, primary, Bannon, Lian, additional, Sharar Fischler, Tali, additional, Truyens, Marie, additional, Vavricka, Stephan R., additional, Tepes, Katja, additional, Pugliese, Daniela, additional, Savarino, Edoardo V., additional, Zittan, Eran, additional, Drobne, David, additional, Roblin, Xavier, additional, Bar-Gil Shitrit, Ariella, additional, Armuzzi, Alessandro, additional, Lobaton, Triana, additional, Maharshak, Nitsan, additional, Yanai, Henit, additional, Ben-Horin, Shomron, additional, and Kopylov, Uri, additional

Published
2023
Full Text
View/download PDF

68. QINGDAI (QD) FOR PATIENTS WITH ACTIVE ULCERATIVE COLITIS: A RETROSPECTIVE ISRAELI NATIONAL EXPERIENCE

Author

Kopylov, Uri, primary, Salomon, Nir, additional, Zittan, Eran, additional, Lahat, Adi, additional, Eliakim, Rami, additional, Weiss, Batia, additional, Koslowsky, Benjamin, additional, Gil, Ariella Shitrit-Bar, additional, Saban, Lotem, additional, Maharshak, Nitsan, additional, Hirsch, Ayal, additional, Ritter, Einat, additional, Shahar, Eyal, additional, Tamir, Natalie, additional, Dotan, Iris, additional, Ben-Horin, Shomron, additional, and Yanai, Henit, additional

Published
2023
Full Text
View/download PDF

70. Spatiotemporal analysis of small bowel capsule endoscopy videos for outcomes prediction in Crohn’s disease

Author

Kellerman, Raizy, primary, Bleiweiss, Amit, additional, Samuel, Shimrit, additional, Margalit-Yehuda, Reuma, additional, Aflalo, Estelle, additional, Barzilay, Oranit, additional, Ben-Horin, Shomron, additional, Eliakim, Rami, additional, Zimlichman, Eyal, additional, Soffer, Shelly, additional, Klang, Eyal, additional, and Kopylov, Uri, additional

Published
2023
Full Text
View/download PDF

73. sj-docx-1-tag-10.1177_17562848231172556 – Supplemental material for Spatiotemporal analysis of small bowel capsule endoscopy videos for outcomes prediction in Crohn’s disease

Author

Kellerman, Raizy, Bleiweiss, Amit, Samuel, Shimrit, Margalit-Yehuda, Reuma, Aflalo, Estelle, Barzilay, Oranit, Ben-Horin, Shomron, Eliakim, Rami, Zimlichman, Eyal, Soffer, Shelly, Klang, Eyal, and Kopylov, Uri

Subjects
Oncology and Carcinogenesis not elsewhere classified, Pharmacology and Pharmaceutical Sciences not elsewhere classified, Nutrition and Dietetics not elsewhere classified
Abstract

Supplemental material, sj-docx-1-tag-10.1177_17562848231172556 for Spatiotemporal analysis of small bowel capsule endoscopy videos for outcomes prediction in Crohn’s disease by Raizy Kellerman, Amit Bleiweiss, Shimrit Samuel, Reuma Margalit-Yehuda, Estelle Aflalo, Oranit Barzilay, Shomron Ben-Horin, Rami Eliakim, Eyal Zimlichman, Shelly Soffer, Eyal Klang and Uri Kopylov in Therapeutic Advances in Gastroenterology

Published
2023
Full Text
View/download PDF

75. Outcome of inflammatory bowel disease patients with prior malignancy.

Author

Shani, Uria, Klang, Eyal, Lassman, Simon, Ungar, Bella, Ben-Horin, Shomron, and Kopylov, Uri

Subjects
INFLAMMATORY bowel diseases, SECONDARY primary cancer
Abstract

Background Inflammatory bowel disease (IBD) treatment options, such as anti-tumor necrosis factor (TNF) agents and thiopurines, are associated with an increased risk of certain malignancies. However, the management of IBD patients with prior malignancy is not well defined and the literature is scarce. The main aim of this study was to describe the outcome of IBD patients with prior malignancy, or malignancy before first exposure to IBD-related biologic or immunosuppressive treatment. Methods The study cohort included adult IBD patients followed in a tertiary academic center, with at least one malignancy diagnosed before IBD diagnosis or before initiation of IBD-related treatment. The main outcome of interest was a relapse of the previous malignancy or development of a second malignancy. Results Our database included 1112 patients with both IBD and malignancy. Of these, 86 (9%) who had their malignancy diagnosed before IBD-related treatment initiation were identified, while 10/86 patients (9%) were further diagnosed with a second primary malignancy. Twenty patients, (20/86, 23%) had recurrence of a previous malignancy, most commonly non-melanoma skin cancer (NMSC), found in 9/20 patients (45%). Treatment with infliximab was found to be significantly associated with recurrence of NMSC (P=0.003). Conclusions Anti-TNF treatment may be associated with an increased risk of NMSC recurrence. This underscores the importance of rigorous dermatological follow up in IBD patients with previous NMSC treated with anti-TNFs. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

76. Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease—A Multicenter Retrospective European Study

Author

Kopylov, Uri, Verstockt, Bram, Biedermann, Luc, Sebastian, Shaji, Pugliese, Daniela, Sonnenberg, Elena, Steinhagen, Peter, Arebi, Naila, Ron, Yulia, Kucharzik, Torsten, Roblin, Xavier, Ungar, Bella, Shitrit, Ariella Bar-Gil, Ardizzone, Sandro, Molander, Pauliina, Coletta, Marina, Peyrin-Biroulet, Laurent, Bossuyt, Peter, Avni-Biron, Irit, Tsoukali, Emmanouela, Allocca, Mariangela, Katsanos, Konstantinos, Raine, Tim, Sipponen, Taina, Fiorino, Gionata, Ben-Horin, Shomron, Eliakim, Rami, Armuzzi, Alessandro, Siegmund, Britta, Baumgart, Daniel C, Kamperidis, Nikolaos, Maharshak, Nitsan, Maaser, Christian, Mantzaris, Gerassimos, Yanai, Henit, Christodoulou, Dimitrious K, Dotan, Iris, and Ferrante, Marc

Published
2018
Full Text
View/download PDF

80. ECCO Guidelines on Inflammatory Bowel Disease and Malignancies

Author

Gordon, Hannah, primary, Biancone, Livia, additional, Fiorino, Gionata, additional, Katsanos, Konstantinos H, additional, Kopylov, Uri, additional, Sulais, Eman Al, additional, Axelrad, Jordan E, additional, Balendran, Karthiha, additional, Burisch, Johan, additional, de Ridder, Lissy, additional, Derikx, Lauranne, additional, Ellul, Pierre, additional, Greuter, Thomas, additional, Iacucci, Marietta, additional, Di Jiang, Caroline, additional, Kapizioni, Christina, additional, Karmiris, Konstantinos, additional, Kirchgesner, Julien, additional, Laharie, David, additional, Lobatón, Triana, additional, Molnár, Tamás, additional, Noor, Nurulamin M, additional, Rao, Rohit, additional, Saibeni, Simone, additional, Scharl, Michael, additional, Vavricka, Stephan R, additional, and Raine, Tim, additional

Published
2022
Full Text
View/download PDF

81. Idiopathic Thrombocytopenic Purpura associated with Inflammatory Bowel Disease: a multi-centre ECCO CONFER case series

Author

Mahajna, Hussein, primary, Verstockt, Bram, additional, Bergemalm, Daniel, additional, Castiglione, Fabiana, additional, Rodríguez-Moranta, Fransisco, additional, Savarino, Edoardo Vincenzo, additional, Hoentjen, Frank, additional, Bessissow, Talat, additional, Pokryszka, Jagoda, additional, Cremer, Anneline, additional, Eder, Piotr, additional, Truyens, Marie, additional, Yerushalmy-Feler, Anat, additional, Garcia, Maria Jose, additional, and Kopylov, Uri, additional

Published
2022
Full Text
View/download PDF

82. Response to Hassan et al.

Author

Levy, Idan, primary, Bruckmayer, Liora, additional, Klang, Eyal, additional, Ben-Horin, Shomron, additional, and Kopylov, Uri, additional

Published
2022
Full Text
View/download PDF

84. Deep Learning Multi-Domain Model Provides Accurate Detection and Grading of Mucosal Ulcers in Different Capsule Endoscopy Types

Author

Kratter, Tom, primary, Shapira, Noam, additional, Lev, Yarden, additional, Mauda, Or, additional, Moshkovitz, Yehonatan, additional, Shitrit, Roni, additional, Konyo, Shani, additional, Ukashi, Offir, additional, Dar, Lior, additional, Shlomi, Oranit, additional, Albshesh, Ahmad, additional, Soffer, Shelly, additional, Klang, Eyal, additional, Ben Horin, Shomron, additional, Eliakim, Rami, additional, Kopylov, Uri, additional, and Margalit Yehuda, Reuma, additional

Published
2022
Full Text
View/download PDF

85. A Novel Prediction Tool for Endoscopic Intervention in Patients with Acute Upper Gastro-Intestinal Bleeding

Author

Veisman, Ido, primary, Oppenheim, Amit, additional, Maman, Ronny, additional, Kofman, Nadav, additional, Edri, Ilan, additional, Dar, Lior, additional, Klang, Eyal, additional, Sina, Sigal, additional, Gabriely, Daniel, additional, Levy, Idan, additional, Beylin, Dmitry, additional, Beylin, Ortal, additional, Shekel, Efrat, additional, Horesh, Nir, additional, and Kopylov, Uri, additional

Published
2022
Full Text
View/download PDF

86. Development of a Core Outcome Set for Real-world Data in Inflammatory Bowel Disease: A European Crohn’s and Colitis Organisation [ECCO] Position Paper

Author

Hanzel, Jurij, primary, Bossuyt, Peter, additional, Pittet, Valerie, additional, Samaan, Mark, additional, Tripathi, Monika, additional, Czuber-Dochan, Wladyslawa, additional, Burisch, Johan, additional, Leone, Salvatore, additional, Saldaña, Roberto, additional, Baert, Filip, additional, Kopylov, Uri, additional, Jäghult, Susanna, additional, Adamina, Michel, additional, Arebi, Naila, additional, and Gecse, Krisztina, additional

Published
2022
Full Text
View/download PDF

91. Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort study

Author

Avni‐Biron, Irit, primary, Mishael, Tali, additional, Zittan, Eran, additional, Livne‐Margolin, Moran, additional, Zinger, Adar, additional, Tzadok, Roie, additional, Goldenberg, Rosie, additional, Kopylov, Uri, additional, Ron, Yulia, additional, Hadar, Eran, additional, Helman, Sarit, additional, Granovsky, Sorina Grisaru, additional, Ollech, Jacob E., additional, Arazi, Ayelet, additional, Farkash, Rivka, additional, Pauker, Maor H., additional, Yanai, Henit, additional, Dotan, Iris, additional, and Shitrit, Ariella Bar‐Gil, additional

Published
2022
Full Text
View/download PDF

94. Immune function in newborns with in-utero exposure to anti-TNFα therapy

Author

Weiss, Batia, primary, Ben-Horin, Shomron, additional, Lev, Atar, additional, Broide, Efrat, additional, Yavzori, Miri, additional, Lahat, Adi, additional, Kopylov, Uri, additional, Picard, Orit, additional, Eliakim, Rami, additional, Ron, Yulia, additional, Avni-Biron, Irit, additional, Yerushalmy-Feler, Anat, additional, Assa, Amit, additional, Somech, Raz, additional, and Bar-Gil Shitrit, Ariella, additional

Published
2022
Full Text
View/download PDF

98. Endoscopic Postoperative Recurrence in Crohn’s Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study

Author

Yanai, Henit, primary, Kagramanova, Anna, additional, Knyazev, Oleg, additional, Sabino, João, additional, Haenen, Shana, additional, Mantzaris, Gerassimos J, additional, Mountaki, Katerina, additional, Armuzzi, Alessandro, additional, Pugliese, Daniela, additional, Furfaro, Federica, additional, Fiorino, Gionata, additional, Drobne, David, additional, Kurent, Tina, additional, Yassin, Sharif, additional, Maharshak, Nitsan, additional, Castiglione, Fabiana, additional, de Sire, Roberto, additional, Nardone, Olga Maria, additional, Farkas, Klaudia, additional, Molnar, Tamas, additional, Krznaric, Zeljko, additional, Brinar, Marko, additional, Chashkova, Elena, additional, Livne Margolin, Moran, additional, Kopylov, Uri, additional, Bezzio, Cristina, additional, Bar-Gil Shitrit, Ariella, additional, Lukas, Milan, additional, Chaparro, María, additional, Truyens, Marie, additional, Nancey, Stéphane, additional, Lobaton, Triana, additional, Gisbert, Javier P, additional, Saibeni, Simone, additional, Bacsúr, Péter, additional, Bossuyt, Peter, additional, Schulberg, Julien, additional, Hoentjen, Frank, additional, Viganò, Chiara, additional, Palermo, Andrea, additional, Torres, Joana, additional, Revés, Joana, additional, Karmiris, Konstantinos, additional, Velegraki, Magdalini, additional, Savarino, Edoardo, additional, Markopoulos, Panagiotis, additional, Tsironi, Eftychia, additional, Ellul, Pierre, additional, Calviño Suárez, Cristina, additional, Weisshof, Roni, additional, Ben-Hur, Dana, additional, Naftali, Timna, additional, Eriksson, Carl, additional, Koutroubakis, Ioannis E, additional, Foteinogiannopoulou, Kalliopi, additional, Limdi, Jimmy K, additional, Liu, Eleanor, additional, Surís, Gerard, additional, Calabrese, Emma, additional, Zorzi, Francesca, additional, Filip, Rafał, additional, Ribaldone, Davide Giuseppe, additional, Snir, Yifat, additional, Goren, Idan, additional, Banai-Eran, Hagar, additional, Broytman, Yelena, additional, Amir Barak, Hadar, additional, Avni-Biron, Irit, additional, Ollech, Jacob E, additional, Dotan, Iris, additional, and Aharoni Golan, Maya, additional

Published
2022
Full Text
View/download PDF

100. Nomenclature and Definition of Atrophic Lesions in Small Bowel Capsule Endoscopy: A Delphi Consensus Statement of the International CApsule endoscopy REsearch (I-CARE) Group

Author

Elli, Luca, primary, Marinoni, Beatrice, additional, Sidhu, Reena, additional, Bojarski, Christian, additional, Branchi, Federica, additional, Tontini, Gian Eugenio, additional, Chetcuti Zammit, Stefania, additional, Khater, Sherine, additional, Eliakim, Rami, additional, Rondonotti, Emanuele, additional, Saurin, Jean Cristhophe, additional, Bruno, Mauro, additional, Buchkremer, Juliane, additional, Cadoni, Sergio, additional, Cavallaro, Flaminia, additional, Dray, Xavier, additional, Ellul, Pierre, additional, Urien, Ignacio Fernandez, additional, Keuchel, Martin, additional, Kopylov, Uri, additional, Koulaouzidis, Anastasios, additional, Leenhardt, Romain, additional, Baltes, Peter, additional, Beaumont, Hanneke, additional, Marmo, Clelia, additional, McNamara, Deirdre, additional, Mussetto, Alessandro, additional, Nemeth, Artur, additional, Cuadrado Robles, Enrique Perez, additional, Perrod, Guillame, additional, Rahmi, Gabriel, additional, Riccioni, Maria Elena, additional, Robertson, Alexander, additional, Spada, Cristiano, additional, Toth, Ervin, additional, Triantafyllou, Konstantinos, additional, Wurm Johansson, Gabriele, additional, and Rimondi, Alessandro, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results